Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers

Psychopharmacology

Volumn 181, Issue 3, 2005, Pages 504-510

  Sofuoglu, Mehmet ^a   Mouratidis, Maria ^a   Yoo, Sonah ^a   Culligan, Kerry ^b   Kosten, Thomas ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Naval Air Station ^*  (United States)

Author keywords

GABA; i.v. nicotine; Nicotine; Nicotine abstinence; Stroop; Tiagabine

Indexed keywords

NICOTINE; PLACEBO; SODIUM CHLORIDE; TIAGABINE;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COGNITION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GABAERGIC SYSTEM; HEART RATE; HUMAN; MALE; PERFORMANCE; PHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION; WITHDRAWAL SYNDROME;

ADULT; ANTICONVULSANTS; AROUSAL; ATTENTION; BLOOD PRESSURE; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HEART RATE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NIPECOTIC ACIDS; REWARD; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 26944460750     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0010-y     Document Type: Article

References (42)

1. Benowitz NL (1996) Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol 36:597-613
2. Berigan T (2002) Treatment of posttraumatic stress disorder with tiagabine. Can J Psychiatry 47(8):788
3. Bevins RA, Besheer J, Pickett KS (2001) Nicotine-conditioned locomotor activity in rats: dopaminergic and GABAergic influences on conditioned expression. Pharmacol Biochem Behav 68 (1):135-145
4. Brodie MJ (1995) Tiagabine pharmacology in profile. Epilepsia 36 (Suppl 6):S7-S9
5. Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC (2003) Effects of the nicotine patch on performance during the first week of smoking cessation. Nicotine Tob Res 5(2):169-180
6. Cousins MS, Stamat HM, de Wit H (2001) Effects of a single dose of baclofen on self-reported subjective effects and tobacco smoking. Nicotine Tob Res 3(2):123-129
7. Dalby NO (2000) GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology 39(12):2399-2407
8. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby CR Jr (1999) A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31(1):76-86
9. Fan J, Flombaum JI, McCandliss BD, Thomas KM, Posner MI (2003) Cognitive and brain consequences of conflict. NeuroImage 18 (1):42-57
10. Fink-Jensen A, Suzdak PD, Swedberg MD, Judge ME, Hansen L, Nielsen PG (1992) The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur J Pharmacol 220(2-3):197-201
11. Genton P, Guerrini R, Perucca E (2001) Tiagabine in clinical practice. Epilepsia 42(Suppl):342-345
12. Golden C (1978) Stroop color and word test: a manual for clinical and experimental uses. Stoelting Company, Chicago, IL
13. Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR (2003) Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98(11):1625-1632
14. Gross TM, Jarvik ME, Rosenblatt MR (1993) Nicotine abstinence produces content-specific Stroop interference. Psychopharmacology 110(3):333-336
15. Heatherton TF, Kozlowski LT, Frecker T, Fagerström KO (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86(9):1119-1127
16. Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234(1):1-12
17. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43(3):289-294
18. Hughes JR, Hatsukami DK (1997) Effects of three doses of transdermal nicotine on post-cessation eating, hunger and weight. J Subst Abuse 9151-9159
19. Jones HE, Garrett BE, Griffiths RR (1999) Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. J Pharmacol Exp Ther 288(1):188-197
20. Juliano LM, Brandon TH (1998) Reactivity to instructed smoking availability and environmental cues: evidence with urge and reaction time. Exp Clin Psychopharmacol 6(1):45-53
21. Kenford SL, Smith SS, Wetter DW, Jorenby DE, Fiore MC, Baker TB (2002) Predicting relapse back to smoking: contrasting affective and physical models of dependence. J Consult Clin Psychol 70(1):216-227
22. Kos J, Hasenfratz M, Battig K (1997) Effects of a 2-day abstinence from smoking on dietary, cognitive, subjective, and physiologic parameters among younger and older female smokers. Physiol Behav 61(5):671-678
23. Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR (2004) Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug Alcohol Depend 76(1):81-91
24. Mancuso G, Warburton DM, Melen M, Sherwood N, Tirelli E (1999) Selective effects of nicotine on attentional processes. Psychopharmacology (Berl) 146(2):199-204
25. Mansvelder HD, Keath JR, McGehee DS (2002) Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33(6):905-919
26. McNair D, Lorr M, Dropperman L (1971) Manual for profile of mood states. Educational and Industrial Testing Services, San Diego, CA
27. Novak V, Kanard R, Kissel JT, Mendell JR (2001) Treatment of painful sensory neuropathy with tiagabine: a pilot study. Clin Auton Res 11(6):357-361
28. Paterson NE, Markou A (2002) Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat. Synapse 44(4):252-253
29. Perkins KA, D'Amico D, Sanders M, Grobe JE, Wilson A, Stiller RL (1996) Influence of training dose on nicotine discrimination in humans. Psychopharmacology (Berl) 126(2):132-139
30. Pidoplichko VI, Noguchi J, Areola OO, Liang Y, Peterson J, Zhang T, Dani JA (2004) Nicotinic cholinergic synaptic mechanisms in the ventral tegmental area contribute to nicotine addiction. Learn Mem 11(1):60-69
31. Provost SC, Woodward R (1991) Effects of nicotine gum on repeated administration of the Stroop test. Psychopharmacology (Berl) 104(4):536-540
32. Quick MW, Lester RA (2002) Desensitization of neuronal nicotinic receptors. J Neurobiol 53(4):457-478
33. Reeves D, Winter K, Kane R, Elsmore T, Bleiberg J (2002) ANAM 2001 User's Manual. National Cognitive Recovery Foundation, San Diego, CA
34. Rosenthal M (2003) Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control. J Clin Psychiatry 64(10):1245-1249
35. Sayette MA, Hufford MR (1994) Effects of cue exposure and deprivation on cognitive resources in smokers. J Abnorm Psychol 103(4):812-818
36. Schachter SC (2001) Pharmacology and clinical experience with tiagabine. Expert Opin Pharmacother 2(1):179-187
37. Watkins SS, Koob GF, Markou A (2000) Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2(1):19-37
38. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54(6):1063-1070
39. Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J (1999) Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 517(Pt 2):591-597
40. Wickens CD, Kessel C (1980) Processing resource demands of failure detection in dynamic systems. J Exp Psychol Hum Percept Perform 6(3):564-577
41. Zwanzger P, Baghai TC, Schule C, Minov C, Padberg F, Moller HJ, Rupprecht R (2001) Tiagabine improves panic and agoraphobia in panic disorder patients. J Clin Psychiatry 62(8):656-657
42. Zwanzger P, Eser D, Padberg F, Baghai TC, Schule C, Rotzer F, Ella R, Moller HJ, Rupprecht R (2003) Effects of tiagabine on cholecystokinin- tetrapeptide (CCK-4)-induced anxiety in healthy volunteers. Depress Anxiety 18(3):140-143